Impactful Policy Action to Reduce Drug Costs in Managing Critically Ill Patients with COVID-19

Mayo Clin Proc. 2020 Aug;95(8):1808-1809. doi: 10.1016/j.mayocp.2020.06.042. Epub 2020 Jun 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections*
  • Critical Illness*
  • Drug Costs
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2